Praxis Precision Medicines, Inc.
PRAX
$37.32
-$1.10-2.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 1,349.13% | -35.47% | -54.29% | -36.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 1,349.13% | -35.47% | -54.29% | -36.90% |
| Cost of Revenue | 125.34% | 206.11% | 142.65% | 6.43% | 5.80% |
| Gross Profit | -129.00% | -173.18% | -147.61% | -8.34% | -6.98% |
| SG&A Expenses | -9.20% | 52.33% | 74.87% | 4.52% | 15.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.59% | 152.18% | 119.89% | 5.89% | 9.14% |
| Operating Income | -78.41% | -130.01% | -122.74% | -7.23% | -9.96% |
| Income Before Tax | -75.20% | -118.32% | -110.74% | 4.77% | -5.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.20% | -118.32% | -110.74% | 4.77% | -5.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.20% | -118.32% | -110.74% | 4.77% | -5.60% |
| EBIT | -78.41% | -130.01% | -122.74% | -7.23% | -9.96% |
| EBITDA | -78.77% | -130.76% | -123.34% | -7.25% | -9.97% |
| EPS Basic | -15.70% | 0.99% | -0.87% | 76.48% | 73.11% |
| Normalized Basic EPS | -17.49% | -1.35% | -0.87% | 76.48% | 73.02% |
| EPS Diluted | -15.70% | 0.99% | -0.87% | 76.48% | 73.11% |
| Normalized Diluted EPS | -17.49% | -1.35% | -0.87% | 76.48% | 73.02% |
| Average Basic Shares Outstanding | 51.43% | 120.51% | 108.91% | 304.88% | 292.76% |
| Average Diluted Shares Outstanding | 51.43% | 120.51% | 108.91% | 304.88% | 292.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |